Latest Episodes
3
Case-based discussion on which mCSPC patients benefit from early treatment intensification
COR2ED Medical Education: Assoc. Prof. Shilpa Gupta and Dr Fabio Schutz, discuss early treatment intensification with triplet therapy for metastatic castration-sensitive prostate cancer (mCSPC)...
3
Overview of efficacy and safety data of combination therapy with PARPi and NHAs
Overview of efficacy and safety data of combination therapy with PARPi and NHAs, incorporating the latest data presented and the impact for the treatment...
1
Advanced HCC and not eligible for IO – what are the treatment options?
COR2ED Medical Education: Prof. Dr James Harding, Medical Oncologist at Memorial Sloan Kettering Cancer Center and Prof. Dr Sammy Saab, Gastroenterologist and Transplant Hepatologist...
2
PARPi and NHA combination therapy for patients with mCRPC – a US and EU perspective
COR2ED Medical Education: Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and...
1
Clinical implementation of PARPi monotherapy for prostate cancer patients – a US and EU perspective
COR2ED Medical Education: Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and...
2
Update from ASCO GI 2023 Ep 2: lower GI cancer highlights
COR2ED Medical Education: This episode, covers the highlights on colorectal cancer from ASCO GI 2023. Prof. Andrea Sartore-Bianchi (Niguada Cancer Center, Milan, Italy) and...